YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
CVS Health (NYSE:CVS) has extended its long-term pharmaceutical distribution agreements with Cardinal Health and McKesson through 2032. The renewed contracts keep CVS Health as a major customer for both wholesalers, supporting its nationwi…
Cardinal Health CAH enters fiscal 2027 with strong momentum across pharmaceutical distribution, specialty solutions and growth businesses. Specialty pharmaceuticals, cell-and-gene therapy capabilities and expanding non-core operations shou…
CVS Health CVS raised its full-year outlook for the Health Care Benefits segment after reporting stronger underlying performance in the first half of the year. The company now expects adjusted operating income in the range of $5.03-$5.37 b…
1 Healthcare Stock with Exciting Potential and 2 We Find Risky Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks…
Cardinal Health (CAH) closed at $233.12 in the latest trading session, marking a +2.11% move from the prior day. This change outpaced the S&P 500's 0.66% gain on the day. Meanwhile, the Dow gained 0.18%, and the Nasdaq, a tech-heavy index,…
MarketsandMarkets Research Pvt. Ltd. Delray Beach, FL , Oct. 05, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global disposable medical devices market to grow from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, at a…
In October 2026, Cardinal Health announced it had entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, maintaining the current scope of distribution services. This lon…
Wall Street closed in the green on Friday after the September nonfarm payrolls report came in cooler than economists expected. The blue-chip Dow ended up 0.5%, the benchmark S&P 500 gained 0.7%, and the tech-focused Nasdaq Composite advanc…
For Immediate Release Chicago, IL – October 2, 2026 – Today, Zacks Equity Research discusses McKesson MCK, Cardinal Health CAH, Becton, Dickinson and Co. BDX, Merit Medical Systems MMSI and ProDex PDEX. Industry: Dental Supplies Link: http…
Investing.com -- Cardinal Health Inc (NYSE:CAH) shares rose 3.7% in Thursday trading after the company announced an extension of its drug distribution agreement with CVS Health through June 2032. Before you buy NVIDIA: our AI model's stock…
The Zacks Medical – Dental Supplies industry is benefiting from several structural healthcare shifts. Demand continues to benefit from stable healthcare utilization, continued expansion of specialty medicines, increasing adoption of biolog…
DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the…
DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2027 on November 5, prior to the opening of trading on the New York Stock Exchange. The company wil…
Cardinal Health (CAH): Buy, Sell, or Hold Post Q2 Earnings? Even though Cardinal Health (currently trading at $220.37 per share) has gained 6.8% over the last six months, it has lagged the S&P 500's 22.1% return during that period. This ma…
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fu…
In the latest trading session, Cardinal Health (CAH) closed at $220.22, marking a -1.08% move from the previous day. This move lagged the S&P 500's daily gain of 0.51%. Meanwhile, the Dow experienced a rise of 0.93%, and the technology-dom…
McKesson (MCK) is back in focus after its share price dipped 1.2%, trailing the broader market, as investors weigh mixed earnings estimates against the company's raised full-year adjusted EPS guidance and specialty-led healthcare footprint…
Cardinal Health has been a powerful performer over the past several years. The question now is whether the current share price lines up with what the business is earning. With the stock pulling back slightly in the short term after a stron…
Cardinal Health CAH and McKesson MCK are direct competitors in U.S. pharmaceutical distribution, with both increasingly leveraging specialty pharmaceuticals, provider platforms and technology to expand beyond traditional distribution. CAH'…
GE HealthCare Technologies Inc. (NASDAQ:GEHC) specializes in hospital imaging, including MRI, CT, and ultrasound machines, and the contrast agents required to interpret scans. Spun out of General Electric in early 2023, GE HealthCare trade…
Company Logo Profiles 3M, Medline, Cardinal Health, Medtronic and DuPont, covering competitors, segments, regional shares, trends and opportunities. Medical Textile MarketMedical Textile Market Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "M…
2 Large-Cap Stocks with Solid Fundamentals and 1 We Brush Off Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding…
In the latest trading session, Cardinal Health (CAH) closed at $222.04, marking a -1.64% move from the previous day. Elsewhere, the Dow lost 0.36%, while the tech-heavy Nasdaq added 0.45%. Coming into today, shares of the prescription drug…
The global healthcare services market has expanded steadily in recent years. The market size is expected to reach $11.32 trillion by 2030, at a compound annual growth rate (CAGR) of 4.9% (per The Business Research). Over the coming years,…
Cardinal Health CAH is increasingly using its multi-specialty management services organization (MSO) strategy to expand its presence in specialty care delivery. The company expects its MSO platforms to contribute to growth in fiscal 2027,…
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect…
Key Points Interested in Cencora, Inc.? Here are five stocks we like better. Cencora expects its specialty-focused strategy to drive growth through fiscal 2027, supported by demand in oncology and retina, expanded physician-services capabi…
CVS Health's CVS 2026 revenues are now projected to be at least $414 billion, up from the earlier projection of at least $405 billion. The company also boosted adjusted earnings guidance to $7.90-$8.10 from $7.30-$7.50. However, it faces s…
Key Points Interested in Cencora, Inc.? Here are five stocks we like better. Specialty pharmaceuticals and MSOs are central to Cencora's growth strategy, with particular emphasis on retina and oncology practices. Management expects the MSO…
Key Points Interested in Cardinal Health, Inc.? Here are five stocks we like better. Cardinal Health expects adjusted EPS to grow 13%-15% in fiscal 2027, driven mainly by operating-income growth across its business segments. The company al…
Key Points Interested in Cardinal Health, Inc.? Here are five stocks we like better. Cardinal Health expects growth to normalize in fiscal 2027 after fiscal 2026 benefited from unusually strong specialty growth, customer onboarding, acquis…
Life sciences solutions and products provider Thermo Fisher Scientific (NYSE:TMO)'s shares have done well in September and are up by more than 8% since the 10th. On the 15th, Cramer discussed the strength in the shares in a conversation wi…
Healthcare services and products company Cardinal Health (NYSE:CAH)'s shares are up by more than 10% year-to-date but are down by more than 8% since early September. Cramer discussed the firm's share price performance in his morning appear…
BrightSpring Health Services' BTSG Home and Community Pharmacy business is facing a meaningful revenue setback from the Inflation Reduction Act (IRA), but the company's second-quarter performance suggests operational efficiency is helping…
Cardinal Health CAH has entered fiscal 2027 with regulatory changes remaining a key headwind for its Pharma business, particularly the impact of Inflation Reduction Act (IRA) pricing changes. In the fourth quarter, IRA-related WACC changes…
Cardinal Health logo under a magnifying glass_ By Casimiro Cardinal Health, Inc. (CAH), headquartered in Dublin, Ohio, operates as a healthcare services and products company. Valued at $54.6 billion by market cap, the company's services in…